BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| bifidobacterium longum {B.Longum } - Akkermansia |
📓
Free lipoproteins from Bifidobacterium longum alleviate osteoarthritis through modulation of the gut microbiome. Microbiome research reports (Microbiome Res Rep ) Vol: 2 Issue 3 Pages: 18 Pub: 2023 Epub: 2023 May 11 Authors Sane F , Piva F , Romond MB , Html Article Publication |
| bifidobacterium longum {B.Longum } - Akkermansia |
👪
Ameliorating Effects of Bifidobacterium longum subsp. infantis FB3-14 against High-Fat-Diet-Induced Obesity and Gut Microbiota Disorder. Nutrients (Nutrients ) Vol: 15 Issue 19 Pages: Pub: 2023 Sep 22 Epub: 2023 Sep 22 Authors Kou R , Wang J , Li A , Wang Y , Zhang B , Liu J , Sun Y , Wang S , Html Article Publication |
| bifidobacterium longum {B.Longum } - Akkermansia |
📓
Selenium-enriched Bifidobacterium longum DD98 relieves irritable bowel syndrome induced by chronic unpredictable mild stress in mice. Food & function (Food Funct ) Vol: 14 Issue 11 Pages: 5355-5374 Pub: 2023 Jun 6 Epub: 2023 Jun 6 Authors Jin X , Hu Y , Lin T , Gao F , Xu Z , Hou X , Yin Y , Kan S , Zhu H , Chen D , Publication |
| bifidobacterium longum {B.Longum } - Akkermansia |
📓
The antidiabetic effects of Bifidobacterium longum subsp. longum BL21 through regulating gut microbiota structure in type 2 diabetic mice. Food & function (Food Funct ) Vol: 13 Issue 19 Pages: 9947-9958 Pub: 2022 Oct 3 Epub: 2022 Oct 3 Authors Hao J , Zhang Y , Wu T , Liu R , Sui W , Zhu J , Fang S , Geng J , Zhang M , Publication |
| bifidobacterium longum {B.Longum } - Akkermansia |
📓
Bifidobacterium longum supplementation prevents intestinal inflammation and cognitive impairment in sleep-deprived mice by modulating clock gene expression. Food & function (Food Funct ) Vol: Issue Pages: Pub: 2025 Nov 10 Epub: 2025 Nov 10 Authors Huang L , Li X , Guo M , Lu W , Zhao J , Xiao Y , Chen W , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
